Naveen Kumar Bade, MD | |
522 E 11th St Ste 200, Anniston, AL 36207-4770 | |
(256) 237-5302 | |
(256) 237-5368 |
Full Name | Naveen Kumar Bade |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 14 Years |
Location | 522 E 11th St Ste 200, Anniston, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518340454 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | MD.37316 (Alabama) | Secondary |
207RN0300X | Internal Medicine - Nephrology | 37316 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Rai Jacksonville | Jacksonville, AL | Dialysis facility |
Rai-snow St-oxford | Oxford, AL | Dialysis facility |
Rai East 11th St Anniston | Anniston, AL | Dialysis facility |
Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Nephrology And Hypertension Consultants, P.c. | 6800876053 | 6 |
News Archive
People taking oral steroids are twice as likely as the general population to have severe vitamin D deficiency, according to a study of more than 31,000 children and adults by scientists at Albert Einstein College of Medicine of Yeshiva University.
Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S. Patent and Trademark Office (USPTO) issued a composition of matter patent covering its clinical candidate, MRX-I. MRX-I is a novel antibacterial oxazolidinone that targets infections due to multi-drug resistant Gram-positive pathogens.
Oncotarget published "Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer" which reported that patients with HCV-related cirrhosis are at risk for liver cancer development.
› Verified 4 days ago
Entity Name | Nephrology And Hypertension Consultants, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447349949 PECOS PAC ID: 6800876053 Enrollment ID: O20040720001330 |
News Archive
People taking oral steroids are twice as likely as the general population to have severe vitamin D deficiency, according to a study of more than 31,000 children and adults by scientists at Albert Einstein College of Medicine of Yeshiva University.
Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S. Patent and Trademark Office (USPTO) issued a composition of matter patent covering its clinical candidate, MRX-I. MRX-I is a novel antibacterial oxazolidinone that targets infections due to multi-drug resistant Gram-positive pathogens.
Oncotarget published "Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer" which reported that patients with HCV-related cirrhosis are at risk for liver cancer development.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Naveen Kumar Bade, MD 522 E 11th St Ste 200, Anniston, AL 36207-4770 Ph: (256) 237-5302 | Naveen Kumar Bade, MD 522 E 11th St Ste 200, Anniston, AL 36207-4770 Ph: (256) 237-5302 |
News Archive
People taking oral steroids are twice as likely as the general population to have severe vitamin D deficiency, according to a study of more than 31,000 children and adults by scientists at Albert Einstein College of Medicine of Yeshiva University.
Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S. Patent and Trademark Office (USPTO) issued a composition of matter patent covering its clinical candidate, MRX-I. MRX-I is a novel antibacterial oxazolidinone that targets infections due to multi-drug resistant Gram-positive pathogens.
Oncotarget published "Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer" which reported that patients with HCV-related cirrhosis are at risk for liver cancer development.
› Verified 4 days ago
Dr. Rohit G Patel, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 901 Keith Ave, Anniston, AL 36207 Phone: 256-236-8611 Fax: 256-236-8636 | |
Venugopala S Bheemanathini, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 522 E 11th St, Suite 200, Anniston, AL 36207 Phone: 256-237-5302 Fax: 256-237-5368 | |
Vishala Chindalore, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1010 Christine Ave, Anniston, AL 36207 Phone: 256-236-5631 Fax: 256-236-5637 | |
Dr. Chidiebere Maquincy Ibekwe, M.D, MPH, FACP Nephrology Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5639 | |
Wyndol Span Hamer Jr., M.D Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1700 Christine Ave, Suite 102, Anniston, AL 36207 Phone: 256-294-7004 Fax: 256-294-7005 | |
Almena Free, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-236-5631 Fax: 256-236-5335 | |
Mohamed Jasser, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave, Suite 307, Anniston, AL 36207 Phone: 256-231-8636 Fax: 256-231-8684 |